Levotrex

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Levotrex

Levotrex is a pharmaceutical preparation whose primary active ingredient is Levocetirizine dihydrochloride, a highly potent compound used for the targeted management of allergy symptoms. It is specifically categorized as a second-generation antihistamine and belongs to the broader pharmacological class of Histamine H1-receptor antagonists. The general purpose of Levotrex is to provide effective, targeted relief from the physiological effects of Histamine released during allergic responses.

Property Description
Active ingredient Levocetirizine dihydrochloride
Form Oral tablet and oral solution
Pharmacological class Second-generation Histamine H1-receptor antagonist
Common use General antiallergic management
Origin Synthetic compound

What Type of Medicine is Levotrex and What is its Core Purpose?

Levotrex functions as a selective H1-receptor antagonist, blocking the specific cellular receptor sites that the inflammatory mediator Histamine activates to initiate allergic symptoms. This mechanism is utilized for controlling the systemic responses that drive conditions such as allergic rhinitis and chronic idiopathic urticaria (CIU). The drug's utility is recognized for providing symptomatic treatment for seasonal and perennial allergic rhinitis, which means the medication helps control the body's overreaction to environmental allergens, mitigating discomfort like sneezing and itching.

Levocetirizine: Composition, Origin, and Unique Classification

The active substance in Levotrex, Levocetirizine dihydrochloride, is a synthetic chemical compound designed for oral administration. This compound holds a critical distinction as the pharmacologically active R-enantiomer of the related antihistamine, Cetirizine. This specific composition is why Levocetirizine is noted for demonstrating superior receptor affinity compared to its parent compound, contributing to its enhanced potency. The drug is consistently prepared as a single active ingredient product, delivered in standardized oral tablet and oral solution forms.

How Does Levotrex Work at a Foundational Level?

At its foundation, Levotrex works by providing a robust and selective blockade against the effects of Histamine at the H1 receptor site. Its classification as a second-generation agent is a key differentiating factor; this structural characteristic minimizes its ability to permeate the blood-brain barrier compared to older antihistamines. This characteristic is a factor for patients requiring sustained daily management of allergy symptoms, as it suggests a reduced potential for central nervous system effects like sedation.

What side effects are possible with Levotrex?

Possible Side Effects and Safety Information

The safety profile of Levotrex (Levocetirizine dihydrochloride) is characterized by adverse reactions documented across several System-Organ Classes (SOCs) in official regulatory labeling. These reactions are classified by frequency, based on clinical trial data and post-marketing surveillance.

Frequency Classification Examples of Adverse Reactions
Common (Reported 1/100) Somnolence (drowsiness), Fatigue, Dry mouth, Headache, Nasopharyngitis.
Uncommon (Reported 1/1,000) Asthenia (lack of energy), Abdominal pain.

Serious adverse reactions, though rare, are documented in regulatory sources and include Anaphylaxis and severe hypersensitivity events affecting the immune system. Post-marketing reports have also highlighted rare but clinically significant events such as Urinary Retention and reports of Suicidal Ideation, primarily associated with Nervous System and Psychiatric Disorders categories.

Safety statements in official labeling emphasize specific constraints related to patient status. Levotrex is Contraindicated in individuals with known hypersensitivity to the drug, cetirizine, or any piperazine derivatives. Use is also strictly restricted in patients with End-Stage Renal Disease (Creatinine Clearance less than 10 mL/min) and in children with impaired kidney function. A specific duration-related safety pattern noted in labeling is the reported risk of new-onset, severe Pruritus (itching) that may occur following the discontinuation of the medicine after long-term use. Furthermore, the potential for Impaired Mental Alertness is a key consideration, leading to high-level safety notes concerning co-use with alcohol or other Central Nervous System depressants.

Overdose and Emergency Response

When an ingestion of Levotrex exceeding the therapeutic dose is suspected, immediate medical attention is required. Contacting emergency services or a Poison Control Center is the regulator-mandated first action. The clinical signs of overdose primarily involve central nervous system (CNS) effects, which are documented to differ based on age. In adults, the most frequently reported manifestations are somnolence, leading to pronounced sedation. Conversely, in pediatric patients, overdose may initially present with contrasting symptoms of agitation or restlessness. Other formally recognized signs may include tachycardia, tremor, constipation, and micturition retention.

Due to the potential for exaggerated sedation and other systemic effects, urgent medical help is required when overdose is suspected. The official prescribing information states there is no specific antidote known for levocetirizine. Overdose management is symptomatic and supportive. Procedures such as gastric lavage or the administration of activated charcoal may be considered soon after ingestion to reduce drug absorption, according to regulatory guidelines. Importantly, hemodialysis is stated to be ineffective for removing the active substance, and hospital monitoring may be required based on the severity and persistence of symptoms.

Therapeutic Uses of Levotrex

What Levotrex Treats: Main Uses and Benefits

Levotrex may be applied to support management in clinical settings involving acute or disruptive symptom patterns. Its application is relevant across domains where short-term symptomatic support is needed to help with comfort and assist with maintaining functional stability. Levotrex is commonly used to help with certain distressing symptoms. It is generally applied as part of supportive care.

Levotrex is commonly used to help with symptoms that interfere with daily comfort, such as those associated with conditions characterized by periods of heightened symptoms or fluctuating manifestations. This supportive approach helps address symptom clusters that may become intense or disruptive, and may assist patients during episodes of heightened discomfort. It is often applied during phases when symptoms become more noticeable, particularly those associated with acute or episodic changes. The medication contributes to easing the overall symptom load and supports patients during difficult episodes.

As a treatment in its pharmacological class, it is utilized for managing specific distressing symptoms within a supportive care framework.

Quick Fact: Symptomatic Support for Heightened Symptoms

Levotrex is considered relevant in situations where symptoms related to physiological stress create noticeable strain, offering symptomatic support in the short term.

Eligibility and Restrictions for Use

Population Eligibility and Contraindications

The eligibility for Levotrex (Levocetirizine) is strictly defined by regulatory criteria related to age, known hypersensitivity, and specific organ function status, establishing clear constraints on who can and cannot use the medicine.

Contraindicated Populations

Use is strictly prohibited for patients with a known hypersensitivity to the drug, cetirizine, or any piperazine derivatives. It is also contraindicated in adults and adolescents with End-Stage Renal Disease (creatinine clearance <10 mL/min) or those undergoing hemodialysis. Use is likewise contraindicated for children aged 6 months to 11 years who have any impaired renal function.

Conditional and Restricted Use

  • Age-Related Eligibility: The medicine is contraindicated in infants under 6 months of age. It is approved for use in adults, adolescents 12 years and older, and children 6 months and older (formulation-dependent).
  • Renal/Hepatic Status: For adults and adolescents with moderate to severe renal impairment, use is conditional and requires cautious assessment of kidney function. No restriction is specified for patients with sole hepatic impairment. Older adults also require careful renal status assessment.
  • Other Restrictions: Caution is advised for patients with predisposing factors for urinary retention.

Pregnancy and Lactation

Use of Levotrex is not recommended during pregnancy and is not recommended for women who are breastfeeding, as the drug is known to be excreted into human milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Levotrex based on potential pharmacodynamic reinforcement and restrictions related to systemic clearance.

Documented Interaction Patterns

Category Description Based on Regulatory Documents
Pharmacodynamic Interaction Co-administration with alcohol and other Central Nervous System (CNS) depressants should be avoided. This is due to the potential for additive impairment of CNS performance and additional reduction in alertness.
Clearance Interaction The active substance's clearance is primarily dependent on the kidneys. As a result, the product is formally contraindicated in patients with End-Stage Renal Disease or those undergoing hemodialysis (Creatinine Clearance below 10 mL/min).
Pharmacokinetic Impact Interaction studies involving the parent compound, Cetirizine, showed that co-administration with Ritonavir resulted in a significant increase in plasma exposure (AUC) and decreased clearance of the parent compound.
Metabolic Interaction Levotrex is minimally metabolized (less than 14%). Regulatory data indicates it is unlikely to produce clinically relevant pharmacokinetic interactions through inhibition or induction of liver drug-metabolizing enzymes (CYP450).
Food Interaction Administration with food results in a decrease in the rate of absorption (Tmax is delayed). However, the overall extent of absorption (AUC) is unchanged, meaning the effect is not classified as clinically significant on total systemic exposure.

Regulatory-Defined Constraints

Interaction-related risk is officially noted as heightened in populations with moderate to severe renal impairment (CrCl 10–50 mL/min) due to reduced drug clearance, reflecting the clearance-based constraints of the medication.

Mechanism of Action

The mechanism of action for Levotrex (Levocetirizine) is based on a dual pharmacological approach, targeting both acute signaling and the subsequent cellular phase of inflammation to modulate the systemic response.

H1-Receptor Inverse Agonism and Acute Response

This interaction is defined by the drug's action at the Histamine H1-receptor ( H1R). Levocetirizine acts as an inverse agonist, stabilizing the H1R in an inactive conformation to prevent Histamine binding and subsequent pathway activation. This rapid, high-affinity interaction mechanistically inhibits the Histamine-driven increase in vascular permeability and the excitation of sensory nerves. This results in modulation of acute physiological responses related to mediator release.

Modulation of Cellular Inflammation and Recruitment

Beyond its receptor action, the drug engages mechanisms that influence the downstream process of inflammation. It exerts non- H1R effects by reducing the expression of adhesion molecules ( ICAM-1 and VCAM-1) on endothelial cells. This action limits the capacity of key inflammatory cells, such as Eosinophils, to migrate from the bloodstream into surrounding tissues, resulting in a reduction of inflammatory cell mobility within the pathway.

Dosage and Administration Information

How Levotrex is Used: Administration Overview

Levotrex (levocetirizine dihydrochloride) is for oral administration only, available as a 5 mg film-coated tablet and an oral solution (2.5 mg/5 mL).


Standard Dosing and Timing

Population Standard Daily Dose Maximum Daily Dose Frequency and Timing
Adults and Children ge 12 Years 5 mg 5 mg Once daily, in the evening
Children 6–11 Years 2.5 mg 2.5 mg Once daily, in the evening

The standard adult dose of 5 mg may be reduced to 2.5 mg once daily in some patients. The tablets are typically scored, allowing for the administration of the lower 2.5 mg dose.


Administration Conditions and Adjustments

Levotrex can be taken without regard to food consumption.

Special Population Instruction: The dose involves adjustments for adult patients (ge 12 years) with renal impairment based on their creatinine clearance (CLCR). For example, those with moderate renal impairment (CLCR 30–50 mL/min) are administered 2.5 mg once every other day. No dose adjustment is needed for patients with solely hepatic impairment. For pediatric patients (6 months to 11 years) with impaired renal function, administration of the medicine is prohibited.

Recent Clinical Evidence

Levotrex: Recent Clinical Evidence

This section provides a summary of the available clinical research for Levotrex (Levocetirizine), outlining the types of studies conducted and what the research suggests, without making any statements about individual effectiveness or providing clinical advice.


Evidence for Symptomatic Relief of Allergic Rhinitis

Levotrex was a component of research that explored allergic rhinitis, a condition characterized by fluctuating or episodic manifestations like hay fever. The research base is primarily composed of Randomized Controlled Trials (RCTs) and systematic reviews. These studies were used in research exploring how symptoms change over time and how patient-reported experience was measured. Researchers examined outcomes related to physical discomfort, monitoring changes in symptom severity scores for issues such as sneezing and itching, and changes in outcomes reflecting daily functioning, such as Quality of Life questionnaires. Research included cohorts of adults and adolescents (12 years and older), but also cohorts of children aged 6 to 12 years.

Evidence for Treatment of Chronic Idiopathic Urticaria (CIU)

Levotrex was evaluated in patients with Chronic Idiopathic Urticaria (CIU), a condition where symptoms may vary in intensity and are often characterized by hives and itching. The evidence for this was observed in research derived from RCTs and systematic reviews, applied in research contexts involving fluctuating or unstable symptoms. The studies explored outcomes linked to inflammatory or irritative states, such as measuring the change in itching severity (pruritus) and the frequency and size of hives (wheals). The research so far indicates (soft, non-causal) that studies primarily describe findings over short-term follow-up durations, typically four to six weeks.

Evidence Gaps and Uncertainties

Long-term effects are not fully established beyond intermediate durations (up to six months). There is limited information for long-term outcomes regarding how patterns of symptoms may evolve with continuous use over multiple years. Additionally, data are limited for use in children under 6 years of age. The available research is restricted to the populations studied and does not determine whether an individual will respond similarly.

Frequently Asked Questions (FAQ)

Common questions about Levotrex (FAQ)

Q: How quickly does Levotrex usually start working?

Official studies indicate that the medicine is rapidly absorbed after being taken orally. Peak concentrations are typically reached in the bloodstream within approximately one hour after administration. This characteristic is related to its mechanism of action as an H1-receptor antagonist.


Q: How long do the effects of Levotrex last?

The medicine is generally administered once daily. The duration of the dose is supported by its therapeutic use. Official information states that the plasma half-life—the time it takes for half of the drug to be eliminated from the body—is roughly seven to nine hours in healthy adults.


Q: Is Levotrex the same kind of medicine as [similar drug name]?

Regulatory documents clarify that levocetirizine is a specific chemical form, known as the R-enantiomer, of the related antihistamine, cetirizine. It belongs to the second-generation class of Histamine H1-receptor antagonists.


Q: Why is Levotrex sometimes preferred over other treatment options?

Levocetirizine is categorized as a second-generation antihistamine. This structural characteristic minimizes its ability to permeate the blood-brain barrier compared to older antihistamines. This characteristic has been clinically reviewed in patient populations requiring sustained daily management.


Q: Is it safe to drive a car while taking Levotrex?

Official warnings caution against engaging in activities requiring complete mental alertness, such as driving a motor vehicle or operating machinery. This caution is due to the potential for side effects like somnolence (drowsiness) and a general reduction in alertness.


Q: Is Levotrex suitable for older adults?

Suitability for older adults depends on a careful assessment of their kidney function. Official product information notes that dosing is based on creatinine clearance, a measure of kidney health, as renal clearance may be reduced in this population.


Q: What is the difference between Levotrex and its closest competitor?

The active ingredient in Levotrex is the specific R-enantiomer of the compound cetirizine. Scientific literature notes that this specific compound, levocetirizine, is referenced as demonstrating superior receptor affinity compared to its parent compound.


Q: If I have kidney problems, is Levotrex still an option?

Eligibility is strictly defined by regulatory criteria related to the degree of kidney impairment. Use is strictly prohibited in patients with end-stage renal disease. For patients with moderate to severe renal impairment, conditional use requires cautious assessment of kidney function and dose modification.


Q: What were the primary endpoints measured in the pivotal Levotrex studies?

Studies examining the effects of Levotrex focused on specific measures to determine its action. These measures included changes in patient-reported severity scores for allergy symptoms (such as sneezing and itching) and changes in outcomes reflecting daily functioning, such as Quality of Life questionnaires.


Q: What happens if I miss a scheduled time to take Levotrex?

Regulatory documents state that if a dose is missed, taking it as soon as possible is generally advised. However, if it is almost time for the next scheduled dose, regulatory information indicates the missed dose should be skipped to prevent taking a double dose.


Q: Can Levotrex cause headaches or dizziness?

Official regulatory documents list headache as a common adverse reaction reported in clinical trials. Dizziness is also a reported side effect, though the frequency with which it occurs may vary.


Q: Can Levotrex affect my sleep patterns?

The most commonly reported effect on the nervous system is somnolence (drowsiness). While specific effects on sleep quality are not listed as common side effects, post-marketing reports have included rare cases of trouble sleeping or unusual dreams.


Q: Can I drink alcohol moderately while taking Levotrex?

Official warnings state that concurrent use of this medicine and alcohol should be avoided. This restriction is due to the risk that combining the two substances may lead to additional reductions in mental alertness and further impairment of central nervous system performance.


Q: What should I do if I experience a mild side effect?

Official consumer health information advises contacting a healthcare professional if mild side effects, such as dry mouth or fatigue, become bothersome, severe, or persist. Mild effects may be monitored if they are temporary and manageable.


Q: How long after stopping Levotrex does it take for the drug to leave the system?

The medicine is primarily excreted through the urine, which means elimination depends on kidney function. In adults with normal kidney function, the plasma half-life is approximately seven to nine hours, meaning the active substance is quickly processed.


Q: Is it normal to feel a change in appetite after starting Levotrex?

Official post-marketing surveillance reports have included instances of changes in appetite. These reports have noted both increased and decreased appetite as potential effects, though this is not listed among the most common adverse reactions.


Q: Why is Levotrex not used for all patients with the condition it treats?

The medicine is not suitable for all patients with conditions like allergic rhinitis due to regulatory constraints known as contraindications. These specific situations include known hypersensitivity to the drug itself or having end-stage renal disease (severe kidney failure).


Q: What type of monitoring is done during treatment with Levotrex?

Official regulatory information specifies monitoring for patients with pre-existing health conditions. Specifically, those with moderate to severe renal impairment require careful and ongoing assessment of their kidney function to ensure suitability and proper administration.


Q: Does Levotrex cause weight changes?

According to official documentation, reports of weight gain have been noted as an uncommon adverse reaction during clinical trials. Weight change is not among the most frequently reported effects.


Q: Are there any serious warning signs I should look out for when using Levotrex?

Serious adverse events documented in official sources include symptoms of a severe allergic reaction (such as swelling of the face, throat, or tongue) and rare reports of acute urinary retention.


Q: What is the risk of overdose with Levotrex?

Official safety documents describe that in adults, symptoms of overdose may include increased drowsiness. In children, an overdose may present as initial agitation and restlessness, often followed by increased drowsiness. Supportive care is advised in case of an overdose.


Q: Is it necessary to finish the entire course of Levotrex even if I feel better?

Regulatory sources state this medicine is intended to be taken exactly as directed by the prescribing professional. Official product information notes a rare but severe increase in itching (pruritus) has been reported following the sudden discontinuation of the medicine after long-term use.


Q: Why do people sometimes stop taking Levotrex?

Based on official adverse reaction data, patients commonly stop taking the medicine due to experiencing side effects. The most frequently reported reasons for discontinuation include experiencing common effects like drowsiness, fatigue, or dry mouth.


Q: Is Levotrex generally considered a long-term or short-term treatment?

The duration of treatment depends on the specific condition being managed. Official labeling states the drug is indicated for seasonal allergic rhinitis, which is often short-term, and also for chronic idiopathic urticaria, which may require long-term management.

How should Levotrex be stored and disposed of?

How to Store and Dispose of Levotrex?

Levotrex (levocetirizine dihydrochloride) must be stored strictly according to official regulatory labeling to ensure product stability.


Storage Conditions

Requirement Official Regulatory Statement
Temperature Store at 20 C to 25 C (68 F to 77 F), defined as Controlled Room Temperature.
Handling The oral solution must not be frozen.
Container Keep in the original container and maintain it tightly closed.
Child Safety Keep out of the sight and reach of children.

️ Disposal Instructions

Official disposal rules prioritize using a drug take-back program for unused or expired medicine. If a program is unavailable, non-flushable medicines must be mixed with an undesirable substance (like dirt) and sealed before disposal in the household trash. Do not dispose of the medication via wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Levotrex found in:

A-Z Index: